7th Annual International Congress of Antibodies

Hosting Organization

Information Research Center of International Talent, China State Administration of Foreign Experts Affairs, China

Operating Organization

Foreign Experts Databank of SAFEA-Dalian Biotechnological and Medical  Experts Subdivision, China
BIT Congress Inc., China

Supporting Organization

China Council for the Promotion of International Trade Dalian Sub-Council

Chair

Mr. Hailin Liu, Deputy Director General, China Medicinal Biotech Association, China

Co-Chair

Mr. Ziren Xiao, Deputy Director General, China Medicinal Biotech Association, China

Executive Chair

Dr. Xiaodan Mei, President of BIT Congress Inc., China

Advisory Board Members

Dr. Andreas Baumann, Principal Scientific Expert Biologics, Bayer Schering Pharma AG, Germany
Dr. Arvind Rajpal, Senior Director, Rinat - Pfizer Inc., USA
Dr. Ahmed Al-Qahtani, President and Founder, A & G Skin Solutions, Inc., USA
Dr. Anthony (Tony) Warford , Discipline Leader, Histopathology, AstraZeneca, Innovation Center, China
Dr. C. Thomas Caskey, Professor & Director, University of Texas Health Science Center at Houston, USA
Dr. Christopher Stewart, Senior Director, Asia-Pacific Business Affairs, MPI Research, USA
Dr. Chandra Belani, Professor, Pennsylvania State University College of Medicine, USA
Dr. Chris Ullman, CSO, Isogenica Ltd., UK
Dr. Chulso Moon, Professor, Department of Otolaryngology, The Johns Hopkins University School of Medicine, USA
Dr. Chuck Goolsby, Patterson Professor of Pathology, Director of Flow Cytometry, Department of Pathology, Northwestern University Medical School, USA
Dr. Dimiter Dimitrov, Senior Investigator, NIH, USA
Dr. Christopher J. Mann, Global Head of Application Support and Training, Genetix, UK
Dr. David Wenyan Shen, Executive Director and Head, Biologics Research & GlycoFi, Merck & Co., Inc., USA
Dr. David Basiji, President, CEO and Founder, Amnis Corporation, USA
Dr. Chung  Duck-Hwa, Professor, Gyeongsang National University, Korea
Dr. Davis Farmer, Chairman, MSM Protein Technologies, lnc., USA
Dr. Dewey Ryu, Professor, Director, Biochemical Engineering Program, Department of Chemical Engineering and Material Science, University of California, USA
Dr. Dennis W Harris, Corporate VP and CSO, Millipore Corporation, USA
Dr. Evan B. Siegel, President and CEO, Ground Zero Pharmaceuticals, Inc., USA
Dr. Frank Zhang, CEO, GenScript Corporation, USA
Dr. Ferdinand Bach, CEO, Oncoscience AG, Germany
Dr. Francesco Dazzi, Professor, Department of Haematology, Imperial College at Hammersmith Hospital, UK
Dr. Friedrich Koch-Nolte, Professor, University Medical Center Hamburg-Eppendorf, Germany
Dr. Gowrisankar Rajam, Team Leader, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, USA
Dr. George T. Spencer-Green, Medical Director, Vertex Pharmaceuticals, Inc., USA
Dr. Gilad Gor, President, ORRA Group, LLC, USA
Dr. Haiyan Jiang, Senior Research Scientist, Biologics Research, Centocor, Inc, USA
Dr. Harry R. Hill, Professor & Head, University of Utah, USA
Dr. Herve Perron, CSO, GeNeuro SA, Switzerland
Dr. Haripada Maity, Senior Scientific Manager, Formulation Development, ImClone Systems, A Wholly-Owned Subsidiary of Eli Lilly and Company, USA
Dr. Johannes W. Hell, Professor, University of California at Davis, USA
Dr. John A. McIntyre, Professor & Director, St. Francis Hospital & Health Centers, USA
Dr. John Lowe, Senior Director of Pathology, Genentech, Inc., USA
Dr. Jun Liu, Senior Group Leader and Senior Scientist, Genentech, Inc., USA
Dr. Jianying Dong, Senior Scientist, Oncology Discovery, Biogen Idec, USA
Dr. Juraj Ivanyi, Professor, Clinical and Diagnostic Sciences Department, Kings College London, UK
Dr. Juan Carlos Almagro, Head, Antibody Design Group, Centocor R&D, Inc., USA
Dr. John D. Catravas, Professor, Director, Vascular Biology Center, Medical College of Georgia, USA
Dr. Jenny Ottosson, Director, Department of Proteomics, School of Biotechnology, KTH - Royal Institute of Technology, Sweden
Dr. Jagat R. Kanwar, Professor, Deakin University, Australia
Dr. Kathleen Madden Williams, Partner, Edwards Angell Palmer & Dodge LLP, USA
Dr. Katarzyna Fischer, Head, Laboratory of Department of Rheumatology and Internal Diseases, Pomeranian Medical University of Szczecin, Poland
Dr. Lee M. Nadler, Professor & Senior Vice President, Dana-Farber Cancer Institute, USA
Dr. Leodevico (Vic) L. Ilag, Scientific Advisor, Prima BioMed Limited, Australia
Dr. Larry L. Green, CEO, Ablexis, LLC, USA
Dr. Lionel Rostaing, Professor, Organ Transplant Unit, Toulouse University Hospital, CHU Rangueil, France
Dr. Michael B. Atkins, Professor of Medicine, Harvard Medical School, USA
Dr. Michael G. Rosenblum, Professor & Director, The University of Texas M.D. Anderson Cancer Center, USA
Dr. Michael Parker, Deputy Director, St Vincents Institute of Medical Research, Australia
Dr. Mitchell Ho, Head, Antibody Therapy Unit LMB, National Cancer Institute, National Institues of Health, USA
Dr. NingNing Ma, VP, Process Development, Sino Biological Inc., China
Dr. Nabeela Rasheed, Shareholder, McAndrews, Held & Malloy, Ltd., USA
Dr. Paul Chapman, Head of Biopharm Process Solutions, EMD Millipore, USA
Dr. Paul Wentworth, Professor, the University of Oxford, UK
Dr. Pascale Mathonet, Team Leader, Isogenica Ltd., UK
Dr. Peter L. Bonate, Director, Clinical Pharmacology, Modeling, & Simulation, GlaxoSmithKline, USA
Dr. Peter A. Ward, Stobbe Professor of Pathology, Department of Pathology, University of Michigan Health Systems, USA
Dr. Paul Imbach,Professor, Historical Faculty, University of Basel, Switzerland
Dr. Peter Park, Senior Director, ImmunoGen, Inc., USA
Dr. Ralf Ostendorp, Vice President, Protein Sciences, MorphoSys AG, Germany
Dr. Raymond E. Spier, President, the International Society for Vaccines, UK
Dr. Rajendra Singh, Director, Biology R&D, Caliper Lifesciences, USA
Dr. Rene Labatut, Vice President Global Manufacturing Technology, Sanofi Pasteur Inc., France
Dr. Rostaing, Professor, Organ Transplant Unit, Toulouse University Hospital, CHU Rangueil, France
Dr. Robin E. Butler, Business Development Manager, BTX Harvard Apparatus, USA
Dr. Sarah Fredriksson, CEO, Genovis AB, Sweden
Dr. Scott Knell, Enterprise Architect, Head, Information Technology Strategy, MedImmune, Inc., USA
Dr. Tariq Ghayur, Senior Principal Scientist, Abbott Bioresearch Center, USA
Dr. Tim Pelura, President & CEO, Immunome, Inc., USA
Dr. Timothy Manser, Professor & Chair, The Kimmel Cancer Center, USA
Dr. Teodor Aastrup, CEO, Attana AB, Sweden
Dr. Thomas P. Greco, Associate Clinical Professor, Yale University; Chairman, Dept of Inflammatory Diseases, St. Mary's Hospital, USA
Dr. Titan S. Fan, President, Beacon Analytical Systems, Inc., USA
Dr. Volker Stadler, CEO, PEPperPRINT GmbH, Germany
Dr. Walter Bodmer, Professor, University of Oxford, UK
Dr. Wenle Xia, Director, Oncology Research Laboratory, Duke University Medical Center, USA
Dr. Yajun Guo,Professor, Second Military Medical University, China
Dr. Yan Chen, Senior Vice President, Research, X-BODY BioSciences, USA
Dr. Yun-Hwa Peggy Hsieh, Professor, Department of Nutrition, Food and Exercise Sciences, Florida State University, USA
Dr. Zhengbin (Bing) Yao, Sr. Vice President, Respiratory, Inflammation, and Autoimmunity, MedImmune, USA
Dr. Zhenping  Zhu, EXecutive VP, Kadmon Corp., USA

Local Committee Members